The integrated landscape of driver genomic alterations in glioblastoma
暂无分享,去创建一个
Raul Rabadan | Peter Canoll | Jeffrey N. Bruce | Darell D. Bigner | Tom Mikkelsen | Serena Pellegatta | Francesco Abate | Roger E. McLendon | David J. Pisapia | Antonio Iavarone | Adriana Heguy | Anna Lasorella | Veronique Frattini | Igor Dolgalev | R. McLendon | T. Mikkelsen | K. Aldape | S. Keir | Hai Yan | D. Bigner | A. Iavarone | P. Zoppoli | R. Rabadán | Joseph Chan | A. Heguy | P. Canoll | J. Bruce | G. Finocchiaro | I. Dolgalev | V. Trifonov | G. Privé | A. Lasorella | V. Frattini | Francesco Niola | Angelica M. Castano | Paola Porrati | S. Pellegatta | D. Pisapia | F. Abate | M. Lia | A. Ji | Carla Danussi | Gaurav Gupta | Vladimir Trifonov | Gaetano Finocchiaro | Ken Aldape | Hai Yan | Stephen T. Keir | Pietro Zoppoli | Marie Lia | Paola Porrati | Gilbert G. Privé | Joseph Minhow Chan | Angelica Castano | Alan X. Ji | Francesco Niola | Carla Danussi | Gaurav Gupta | F. Niola | Igor Dolgalev
[1] G. Privé,et al. Crystal Structure of KLHL3 in Complex with Cullin3 , 2013, PloS one.
[2] S. Knapp,et al. Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases. , 2013, The Journal of Biological Chemistry.
[3] K. Aldape,et al. Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis. , 2013, The Journal of clinical investigation.
[4] H. Cross,et al. Mutation of HERC2 causes developmental delay with Angelman-like features , 2012, Journal of Medical Genetics.
[5] Luciana Romão,et al. Glioblastoma: therapeutic challenges, what lies ahead. , 2012, Biochimica et biophysica acta.
[6] Sudha Seshadri,et al. δ-Catenin Is Genetically and Biologically Associated with Cortical Cataract and Future Alzheimer-Related Structural and Functional Brain Changes , 2012, PloS one.
[7] D. Brat,et al. Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma , 2012, Science.
[8] Joshy George,et al. LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin. , 2012, Cancer research.
[9] Steven J. M. Jones,et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes , 2012, Nature.
[10] John L Rubinstein,et al. Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase. , 2012, Structure.
[11] Jill P. Mesirov,et al. MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS , 2012, Nature.
[12] D. Bernardo,et al. Id proteins synchronize stemness and anchorage to the niche of neural stem cells , 2012, Nature Cell Biology.
[13] Paul S Mischel,et al. Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. , 2012, Cancer discovery.
[14] Lynda Chin,et al. Emerging insights into the molecular and cellular basis of glioblastoma. , 2012, Genes & development.
[15] X. Estivill,et al. KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron , 2012, Nature Genetics.
[16] T. Willnow,et al. LRP2 is an auxiliary SHH receptor required to condition the forebrain ventral midline for inductive signals. , 2012, Developmental cell.
[17] Jai Radhakrishnan,et al. Mutations in Kelch-like 3 and Cullin 3 cause hypertension and electrolyte abnormalities , 2012, Nature.
[18] Matthew W. Wilson,et al. A Novel Retinoblastoma Therapy from Genomic and Epigenetic Analyses , 2011, Nature.
[19] Christopher A. Maher,et al. ChimeraScan: a tool for identifying chimeric transcription in sequencing data , 2011, Bioinform..
[20] Michael J. Emanuele,et al. Global Identification of Modular Cullin-RING Ligase Substrates , 2011, Cell.
[21] Kristian Cibulskis,et al. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion , 2011, Nature Genetics.
[22] S. Pileri,et al. BRAF mutations in hairy-cell leukemia. , 2011, The New England journal of medicine.
[23] Gonçalo R. Abecasis,et al. The variant call format and VCFtools , 2011, Bioinform..
[24] Marek Kimmel,et al. Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed , 2011, Human mutation.
[25] A. Katritzky,et al. Chemokine receptor CXCR3 promotes growth of glioma. , 2011, Carcinogenesis.
[26] Michael J. Lush,et al. genenames.org: the HGNC resources in 2011 , 2010, Nucleic Acids Res..
[27] Sally Freels,et al. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. , 2010, Neuro-oncology.
[28] R. Wilson,et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.
[29] Yang Zhang,et al. I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.
[30] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[31] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[32] Wei Keat Lim,et al. The transcriptional network for mesenchymal transformation of brain tumors , 2009, Nature.
[33] Mingming Jia,et al. COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer , 2009, Nucleic Acids Res..
[34] A. Chinnaiyan,et al. Chromosomal aberrations in solid tumors. , 2010, Progress in molecular biology and translational science.
[35] N. Mailand,et al. HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes , 2010, Nature Cell Biology.
[36] Alan F. Rubin,et al. Mutation patterns in cancer genomes , 2009, Proceedings of the National Academy of Sciences.
[37] J Wade Harper,et al. Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases. , 2009, Molecular cell.
[38] Wei Keat Lim,et al. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. , 2009, Developmental cell.
[39] Guoping Fan,et al. BCOR regulates mesenchymal stem cell function by epigenetic mechanisms , 2009, Nature Cell Biology.
[40] E. Ullian,et al. δ-Catenin Regulates Spine and Synapse Morphogenesis and Function in Hippocampal Neurons during Development , 2009, The Journal of Neuroscience.
[41] Albert J. Vilella,et al. EnsemblCompara GeneTrees: Complete, duplication-aware phylogenetic trees in vertebrates. , 2009, Genome research.
[42] K. Kosik,et al. A δ-Catenin Signaling Pathway Leading to Dendritic Protrusions* , 2008, Journal of Biological Chemistry.
[43] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[44] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[45] J. A. Wamstad,et al. Role of the Transcriptional Corepressor Bcor in Embryonic Stem Cell Differentiation and Early Embryonic Development , 2008, PloS one.
[46] M. Budoff,et al. National Institute of Neurological Disorders and Stroke , 2008 .
[47] A. Iavarone,et al. The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein , 2008, Nature Cell Biology.
[48] M. Westphal,et al. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria , 2008, Oncogene.
[49] Dian Donnai,et al. Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes , 2007, Nature Genetics.
[50] J. A. Wamstad,et al. Characterization of Bcor expression in mouse development. , 2007, Gene expression patterns : GEP.
[51] M. Hannink,et al. Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling , 2006, The EMBO journal.
[52] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[53] H. Augustin,et al. The BTB-kelch Protein LZTR-1 Is a Novel Golgi Protein That Is Degraded upon Induction of Apoptosis* , 2006, Journal of Biological Chemistry.
[54] M. Pierotti,et al. Oncogenic rearrangements of the NTRK1/NGF receptor. , 2006, Cancer letters.
[55] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[56] P. Stogios,et al. Sequence and structural analysis of BTB domain proteins , 2005, Genome Biology.
[57] M. Lieberman,et al. Ubiquitination of Keap1, a BTB-Kelch Substrate Adaptor Protein for Cul3, Targets Keap1 for Degradation by a Proteasome-independent Pathway* , 2005, Journal of Biological Chemistry.
[58] Johannes Söding,et al. Protein homology detection by HMM?CHMM comparison , 2005, Bioinform..
[59] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[60] K. Kosik,et al. δ-Catenin at the synaptic–adherens junction , 2005 .
[61] K. Kosik,et al. Delta-catenin at the synaptic-adherens junction. , 2005, Trends in cell biology.
[62] Alcino J. Silva,et al. Deletion of the Neuron-Specific Protein Delta-Catenin Leads to Severe Cognitive and Synaptic Dysfunction , 2004, Current Biology.
[63] David T. Jones,et al. β Propellers: structural rigidity and functional diversity , 1999 .
[64] M. Peter,et al. Ubiquitin-dependent degradation of multiple F-box proteins by an autocatalytic mechanism. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[65] D. van der Kooy,et al. Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. , 1999, Developmental biology.
[66] D. T. Jones,et al. Beta propellers: structural rigidity and functional diversity. , 1999, Current opinion in structural biology.
[67] D K Burns,et al. Defective forebrain development in mice lacking gp330/megalin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[68] L. Muhlbaier,et al. Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents. , 1988, Cancer Research.